Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma.

Nozawa M, Ohzeki T, Tamada S, Hongo F, Anai S, Fujimoto K, Miki T, Nakatani T, Fukasawa S, Uemura H.

Int J Clin Oncol. 2014 Oct 25. [Epub ahead of print]

PMID:
25342378
[PubMed - as supplied by publisher]
2.

Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study.

Miyake M, Tanaka N, Asakawa I, Morizawa Y, Anai S, Torimoto K, Aoki K, Yoneda T, Hasegawa M, Konishi N, Fujimoto K.

Radiat Oncol. 2014 Oct 20;9:208. doi: 10.1186/1748-717X-9-208.

PMID:
25331298
[PubMed - in process]
Free Article
3.

A patient with medulloblastoma in its early developmental stage.

Shinojima N, Nakamura H, Tasaki M, Kameno K, Anai S, Iyama KI, Ando Y, Seto H, Kuratsu JI.

J Neurosurg Pediatr. 2014 Oct 10:1-6. [Epub ahead of print]

PMID:
25303160
[PubMed - as supplied by publisher]
4.

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid.

Nakai Y, Anai S, Kuwada M, Miyake M, Chihara Y, Tanaka N, Hirayama A, Yoshida K, Hirao Y, Fujimoto K.

BMC Urol. 2014 Aug 3;14:59. doi: 10.1186/1471-2490-14-59.

PMID:
25086448
[PubMed - in process]
Free PMC Article
5.

[The control of respiratory organ motion in the field of radiology: the viewpoint of a radiation oncologist].

Nakamura K, Yoshitake T, Terashima K, Sasaki T, Ohga S, Asai K, Matsumoto K, Hirata H, Shinoto M, Yoshidome S, Anai S, Shioyama Y, Honda H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2014 May;70(5):477-82. Japanese. No abstract available.

PMID:
24858293
[PubMed - indexed for MEDLINE]
Free Article
6.

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer.

Tomioka A, Tanaka N, Yoshikawa M, Miyake M, Anai S, Chihara Y, Okajima E, Hirayama A, Hirao Y, Fujimoto K.

BMC Urol. 2014 Apr 29;14:33. doi: 10.1186/1471-2490-14-33.

PMID:
24773608
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Antitumor effect of fibrin glue containing temozolomide against malignant glioma.

Anai S, Hide T, Takezaki T, Kuroda J, Shinojima N, Makino K, Nakamura H, Yano S, Kuratsu J.

Cancer Sci. 2014 May;105(5):583-91. doi: 10.1111/cas.12397. Epub 2014 Apr 19.

PMID:
24673719
[PubMed - indexed for MEDLINE]
8.

Follow-up study of unilateral renal function after nephrectomy assessed by glomerular filtration rate per functional renal volume.

Hosokawa Y, Tanaka N, Mibu H, Anai S, Torimoto K, Yoneda T, Hirayama A, Yoshida K, Hayashi Y, Hirao Y, Fujimoto K.

World J Surg Oncol. 2014 Mar 19;12:59. doi: 10.1186/1477-7819-12-59.

PMID:
24641796
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer.

Miyake M, Nakai Y, Anai S, Tatsumi Y, Kuwada M, Onishi S, Chihara Y, Tanaka N, Hirao Y, Fujimoto K.

Cancer Sci. 2014 May;105(5):616-22. doi: 10.1111/cas.12393. Epub 2014 Apr 6.

PMID:
24602011
[PubMed - indexed for MEDLINE]
10.

Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.

Shimada K, Anai S, Fujii T, Tanaka N, Fujimoto K, Konishi N.

J Pathol. 2013 Dec;231(4):495-504. doi: 10.1002/path.4271.

PMID:
24549646
[PubMed - indexed for MEDLINE]
11.

New treatment strategies to eradicate cancer stem cells and niches in glioblastoma.

Hide T, Makino K, Nakamura H, Yano S, Anai S, Takezaki T, Kuroda J, Shinojima N, Ueda Y, Kuratsu J.

Neurol Med Chir (Tokyo). 2013;53(11):764-72. Epub 2013 Oct 21.

PMID:
24140771
[PubMed - in process]
Free Article
12.

Can a belly board reduce respiratory-induced prostate motion in the prone position?--assessed by cine-magnetic resonance imaging.

Terashima K, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Nonoshita T, Yoshitake T, Atsumi K, Asai K, Hirakawa M, Anai S, Yoshikawa H, Honda H.

Technol Cancer Res Treat. 2013 Oct;12(5):447-53. doi: 10.7785/tcrt.2012.500334. Epub 2013 Mar 26.

PMID:
23547976
[PubMed - in process]
13.

Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy.

Tanaka N, Asakawa I, Anai S, Hirayama A, Hasegawa M, Konishi N, Fujimoto K.

Radiat Oncol. 2013 Jan 30;8:25. doi: 10.1186/1748-717X-8-25.

PMID:
23363647
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Phosphorylation status of Fas-associated death domain protein is associated with biochemical recurrence after radical prostatectomy.

Ikeda T, Tanaka N, Shimada K, Matsumura Y, Miyake M, Anai S, Tomioka A, Okajima E, Hirayama A, Fujimoto K, Konishi N, Hirao Y.

Urology. 2013 Mar;81(3):607-10. doi: 10.1016/j.urology.2012.11.032. Epub 2013 Jan 24.

PMID:
23352370
[PubMed - indexed for MEDLINE]
15.

Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model.

Inoue T, Anai S, Onishi S, Miyake M, Tanaka N, Hirayama A, Fujimoto K, Hirao Y.

BMC Urol. 2013 Jan 5;13:1. doi: 10.1186/1471-2490-13-1.

PMID:
23289871
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression.

Fujii T, Shimada K, Anai S, Fujimoto K, Konishi N.

Cancer Sci. 2013 Mar;104(3):321-7. doi: 10.1111/cas.12089. Epub 2013 Feb 14.

PMID:
23279696
[PubMed - indexed for MEDLINE]
17.

Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor.

Kubo N, Harada T, Anai S, Otsubo K, Yoneshima Y, Ijichi K, Koga T, Takayama K, Nakanishi Y.

Intern Med. 2012;51(17):2399-401. Epub 2012 Sep 1.

PMID:
22975556
[PubMed - indexed for MEDLINE]
Free Article
18.

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer.

Tanaka N, Asakawa I, Fujimoto K, Anai S, Hirayama A, Hasegawa M, Konishi N, Hirao Y.

BMC Urol. 2012 Sep 14;12:28. doi: 10.1186/1471-2490-12-28.

PMID:
22974428
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.

Shimada K, Fujii T, Tsujikawa K, Anai S, Fujimoto K, Konishi N.

Clin Cancer Res. 2012 Oct 1;18(19):5247-55. doi: 10.1158/1078-0432.CCR-12-0955. Epub 2012 Jul 31.

PMID:
22850567
[PubMed - indexed for MEDLINE]
Free Article
20.

Computerized estimation of patient setup errors in portal images based on localized pelvic templates for prostate cancer radiotherapy.

Arimura H, Itano W, Shioyama Y, Matsushita N, Magome T, Yoshitake T, Anai S, Nakamura K, Yoshidome S, Yamagami A, Honda H, Ohki M, Toyofuku F, Hirata H.

J Radiat Res. 2012 Nov 1;53(6):961-72. doi: 10.1093/jrr/rrs043. Epub 2012 Jul 26.

PMID:
22843375
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk